correlational
Analysis v1
20
Pro
0
Against

A nasal spray called esketamine may quickly and lastingly help people with severe depression that hasn’t responded to other treatments — and it might also reduce thoughts of suicide.

Claim Language

Language Strength

association

Uses association language (linked to, correlated with)

The claim uses the phrase 'is associated with,' which indicates a statistical or observational link rather than a direct cause-and-effect relationship. This language avoids claiming that esketamine causes the reduction, only that the two are linked.

Context Details

Domain

medicine

Population

human

Subject

Intranasal esketamine

Action

is associated with

Target

rapid onset and persistent reduction in depressive symptoms, including suicidal ideation

Intervention Details

Type: pharmacological

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Evidence from Studies

Supporting (1)

20

This study found that a nasal spray version of esketamine quickly and lastingly helps people with severe, hard-to-treat depression—especially those thinking about suicide—just like the claim says.

Contradicting (0)

0
No contradicting evidence found